Drug Type Small molecule drug  | 
Synonyms Cefotetan disodium (USP), Cefotetan sodium (JAN), ICI-156834 (free acid) + [5]  | 
Target  | 
Action inhibitors  | 
Mechanism PBPs inhibitors(Bacterial penicillin-binding protein inhibitors), Cell wall inhibitors  | 
Therapeutic Areas  | 
Active Indication  | 
Inactive Indication  | 
Originator Organization  | 
Inactive Organization  | 
License Organization-  | 
Drug Highest PhaseApproved  | 
First Approval Date United States (27 Dec 1985),   | 
Regulation-  | 
Molecular FormulaC17H17N7NaO8S4  | 
InChIKeyBTOFDTWBLNLGSY-DWUNWFSHSA-N  | 
CAS Registry74356-00-6  | 
| KEGG | Wiki | ATC | Drug Bank | 
|---|---|---|---|
| D02228 | Cefotetan Disodium | 
| Indication | Country/Location | Organization | Date | 
|---|---|---|---|
| Bone and joint infections | United States   | 09 Aug 2007 | |
| Gynecological infection | United States   | 09 Aug 2007 | |
| Intraabdominal Infections | United States   | 09 Aug 2007 | |
| Lower Respiratory Tract Infections | United States   | 09 Aug 2007 | |
| Skin and skin structure infections | United States   | 09 Aug 2007 | |
| Urinary Tract Infections | United States   | 09 Aug 2007 | |
| Infectious Diseases | United States   | 27 Dec 1985 | 
| Indication | Highest Phase | Country/Location | Organization | Date | 
|---|---|---|---|---|
| Complicated intra-abdominal infection | Phase 2 | China   | 21 Feb 2017 | |
| Bacterial Infections | Phase 2 | China   | 10 Oct 2012 | |
| Genitourinary tract infection | Phase 2 | China   | 12 Apr 2012 | |
| Skin Diseases, Infectious | Phase 1 | China   | 09 Mar 2015 | |
| Acute Bronchitis | Phase 1 | China   | 26 Jul 2011 | |
| Bronchiectasis | Phase 1 | China   | 26 Jul 2011 | |
| Bronchitis, Chronic | Phase 1 | China   | 26 Jul 2011 | |
| Pneumonia | Phase 1 | China   | 26 Jul 2011 | 





